PDA

View Full Version : Articles of Interest

Pages : 1 2 3 4 5 6 7 8 9 10 11 [12] 13 14 15 16 17 18
  1. Prognostic significance of FOXA1 and GATA-3 in breast cancer
  2. Controversial Cancer Stem Cells Offer New Direction For Treatment
  3. how the breast cancer suppressor gene P16 is silenced
  4. Vitamin-A Derivative Provides Clues To Better Breast Cancer Drugs
  5. Combination therapy for treating breast cancer using antiestrogen, ERA-923, and temsi
  6. The Depressing Thing About Cancer
  7. New Cancer Treatment Shows Promise in Testing
  8. Provectus now compassionate use (limited BC use)
  9. Apocrine sweat gland obstruction by antiperspirants and cancer
  10. Scientists Tackle Viral Mysteries
  11. Light Therapy Offers New Hope For Breast Cancer Patients
  12. New MRI Technique Could Mean Fewer Breast Biopsies In High-Risk Women
  13. PARP Inhibitors Represent New Direction in Cancer Treatment
  14. Targeting inhibitor of apoptosis proteins in combination with ErbB antagonists in bc
  15. The Effect of Modafinil on Cognitive Function in Breast Cancer Survivors
  16. "Fierce 15" for 2009 -Biotech companies with promising products
  17. Breast cancer treatments impact work status
  18. BC likelier for men from Camp Lejeune,NC
  19. Fewer Blood, Bladder, and Stomach Cancers in Vegetarians
  20. Sensors Act as a Chemical Nose to 'Sniff' for Abnormal Cells
  21. Stromal Marker For Breast Cancer Progression Identified
  22. The complexity of cell signalling pathways in oncology
  23. Blood pressure med may help bc.
  24. Less-Toxic Drug PProlongs Survival in Metastatic Breast Cancer
  25. The benefits of vitamin to prevent many cancers.
  26. Saint Barnabas Med. Ctr. is the only...
  27. Newly appreciated membrane ER
  28. Choice of Chemotherapy In Cancer Patients
  29. Wet Ear Wax, Osmidrosis May Be Linked With Breast Cancer Risk
  30. SNP linked to ER-positive, -negative breast cancer risk
  31. Adjuvant Radiotherapy Reduces Recurrences With Small Breast Tumors
  32. Breast Cancer Lung Metastasis Requires Expression of Chemokine Receptor CCR4 & T Cell
  33. Src Helps Breast Cancer Cells To Survive In The Bone Marrow
  34. Predicting Endocrine Therapy Responsiveness in Breast Cancer (lots of info)
  35. One In Three Detected Breast Cancers Is Overdiagnosed
  36. Link Between Migraines And Reduced Breast Cancer Risk Confirmed
  37. Aromatase and bc in the elderly
  38. Most Oncologists Do Not Follow ASCO Guidelines on Fertility Preservation Counseling
  39. Glycemic load of diet tied to bc risk
  40. Relationship Between Age and Axillary Lymph Node Involvement in Women With BC
  41. Antimitotic chemos promote adhesion in detached and circulating tumor cells
  42. Alzheimer's Disease Drug Treats Traumatic Brain Injury
  43. Inhibiting LOX expression decreases tumor cell invasion & mets
  44. Breast Tumor Cells w/PI3K Mutation or HER2 + Selectively Addicted to Akt signaling
  45. Letrozole and tamoxifen differentially affect plasma hormones
  46. NEJM correspondence on trans and other fatty acids
  47. Fda odac opinion
  48. 'New era' in cancer research (Genomics)
  49. Insurers cut back cover for cancer as treatment costs soar
  50. Endocrine resistance...reversed by inhibiting MAPK or PI3K/Akt signaling pathways.
  51. Inhibition of carbonic anhydrase IX: a new strategy against cancer.
  52. BRCA2 Breast Cancer More Sensitive to Chemotherapy
  53. No evidence for link between plasma micronutrient concentrations and postmeno bc
  54. Cancer and Sexuality
  55. Considering Longer Chemotherapy
  56. New way to kill cancer found using body's immune system
  57. Naltrexone: Sufferer joins in battle for trials of 'wonder drug'
  58. Double-edged swords as cancer therapeutics: simultaneously targeting p53 and NF-kappa
  59. Risk of Breast Cancer After Radiotherapy in Childhood Quantified
  60. HER4 associates with increased sensitivity to Herceptin in MBC
  61. FDA Panel Votes Against Adding Doxil to Docetaxel for Advanced Breast Cancer
  62. Hypofractionated and Accelerated Radiotherapy With Subcutaneous Amifostine: Interim
  63. ASTRO Provides Guidance on Use of Partial-Breast Irradiation
  64. Imc-1121b
  65. CD1d-based combination therapy eradicates established tumors in mice.
  66. Sex steroid metabolism polymorphisms and mammographic density in pre- and peri-meno
  67. Patient's own stem cells used to cure cancer
  68. A novel role for STAT5b in beta1 integrin-mediated human breast cancer cell migration
  69. Breast Cancer Drug May Beat Fungal Infection
  70. Ovary Removal Linked to Increased Lung Cancer Risk
  71. Advances Elusive in the Drive to Cure Cancer
  72. Use of antioxidant supplements common during breast cancer treatment
  73. Research into application of thyroid cancer tx to bc
  74. Tumour aromatase expression as a prognostic factor for local control in young bc pts
  75. ridaforolimus may be able to overcome tumors that have become resistant to the cancer
  76. predicting pathologic response of breast cancer to three different chemotherapy regim
  77. Evolving Approaches to Metastatic Breast Cancer Previously Treated with Anthracycline
  78. Blood Pressure Drug (Losartan)Blocks Overexpression of Gene in Breast Cancer Patients
  79. Integration of complementary strategies for gene expression analysis to reveal novel
  80. A Potential Decision-Making Tool for Trastuzumab Use in Breast Cancer
  81. BC-associated metastasis is significantly increased in model of autoimmune arthritis
  82. Routine MRI use at time of dx to evaluate cancer
  83. 'Mindfulness' tips from ABTA
  84. Breast Cancer Patients Increasingly Opting for Mastectomy
  85. Migraine May Lower Breast-Cancer Risk
  86. Lack of Study Volunteers Hobbles Cancer Fight
  87. Inflammation-Associated Biomarkers Predict Breast Cancer Survival
  88. The way we eat....
  89. Cancer Genomes — Continuing Progress
  90. Outcome of Patients Treated With Doxorubicin As a Function of HER2 and TOP2A Status
  91. Cinnamon extract suppresses tumor progression by modulating angiogenesis and the effe
  92. Monotherapy Preferred for Metastatic Breast Cancer
  93. Pre-breast cancer surgery MRI
  94. The Fog That Follows Chemotherapy
  95. Doctor develops DNA vaccine to fight cancer
  96. Moderate Alcohol Consumption Increases Breast Cancer Risk
  97. Cytotoxic effects of antipsychotic drugs implicate cholesterol homeostasis as a novel
  98. Skin telangiectasiae predicts radiation-induced CVD in breast cancer
  99. Breastfeeding Reduces Risk Of Breast Cancer In Women With A Family History Of BC
  100. Characterization of circulating tumor cells vs bone marrow disseminated cells in BC
  101. MicroRNA expression profiling of male breast cancer
  102. Drug Assistance Program
  103. Weight Lifting in Women with Breast-Cancer–Related Lymphedema
  104. Micrometastases or Isolated Tumor Cells and the Outcome of Breast Cancer
  105. Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
  106. melts in your tumor, not in your blood
  107. Hi all!
  108. New Antibiotics (thiazole antibiotics) May Target Cancer-Causing Proteins
  109. How To Fine-Tune An Anti-Cancer Drug : Salinispora tropica
  110. Letrozole Therapy Alone or in Sequence with Tamoxifen in Women with Breast Cancer
  111. Nanoparticulate Gene Therapy of Ovarian Cancer Aces Preclinical Trial
  112. Estrogen Therapy May Be Effective in Treating Breast Cancer Relapse
  113. Dietary and Stored Iron Are Associated With Breast Cancer
  114. Progesterone Leads To Inflammation, A Breast Cancer Risk Factor, Research Reveals
  115. Study finds promise in combined transplant/vaccine therapy for high-risk leukemia
  116. Haploinsufficiency for p190B RhoGAP inhibits MMTV-Neu tumor progression
  117. Patterns and Risk Factors Associated With AI-Related Arthralgia Among BC Survivors
  118. Resident macrophages influence stem cell activity in the mammary gland
  119. Peritoneal Metastasis in Breast Cancer Signals Poor Prognosis
  120. Follow-Up After Grade 1 Breast Cancer May Not Be Needed
  121. International Comparison Reveals US Shortcomings in Clinical Trial Enrollment
  122. Estrogen Shrinks Tumors Refractory to Antiestrogen Therapy
  123. Rare Side Effect Is Seen in Long-Term Use of Tamoxifen
  124. A New Strategy for Immunotherapy of Cancer
  125. Study finds high patient exposure to radiation
  126. Are we HER-ting for innovation in neoadjuvant breast cancer trial design?
  127. New Cancer Drug Delivery System Is Effective and Reversible: aptamers and the liposo
  128. Hot Flashes May Help Guide Breast Cancer Risk Reduction
  129. High dose Fulvestrant more effective than anastrozol for 1st line mets
  130. ? cure in bc populations followed for 23 years
  131. Surprising results of DCIS observation in mice
  132. New Data Confirm Lifestyle Changes Can Dramatically Reduce Risk for Breast Cancer
  133. Use of estradiol after development of resistance to AI
  134. Study mimics human DCIS in mouse models
  135. Breast Cancer: Discovery Leads To Rapid Mouse 'Personalized Trials'
  136. lapatinib before NAB Paclitaxel for advanced malignancies
  137. Delay to formalin fixation effect on breast biomarkers.
  138. Reversal effect and mechanism of lobeline on the multidrug-resistance of human breast
  139. Obesity, Alcohol Use And Smoking Increase The Risk Of Developing A Second Breast Canc
  140. Psychological Intervention Decreases Depression and Inflammation in Breast Cancer Pts
  141. Protein allows cells altered by the oncoprotein ErbB2/HER2 to escape their bonds
  142. Chlorophyllin selenium against cancer
  143. Intra-operative touch preparation cytology following lumpectomy for breast cancer
  144. Outcome of T1N0M0 bc in re: St. Gallen risk assignment criteria for adjuvant therapy
  145. Antioxidants and Cancer: Backwards?
  146. Great article on Vit D helping to prevent cancer...
  147. Little Information About Use And Accuracy Of Breast Cancer Tests
  148. Two New Publications at Breast Cancer Update site
  149. Several Breast Cancer Studies to Be Presented in Berlin May Change Practice
  150. Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
  151. Showerheads may harbor bacteria dangerous to some
  152. Use of progestagens vs progesterone
  153. Occult Nipple Involvement in Breast Cancer
  154. Role of prognostic biomarkers (HR & HER2) in neoadjuvant therapy
  155. Irreversible Electroporation, or IRE: pulsed elctricity to treat cancers
  156. Prostate Cancer Drug Abiraterone Shows Impressive New Research Results (BC trial too)
  157. Pentoxifylline/Vitamin E Combo May Prevent Radiation induced Lymphadema
  158. Sentinel Node Findings Can Guide Axillary Treatment Choice
  159. Heating tumor (sarcoma) helps
  160. Perverse financial incentives tip usage in favor of IV drugs
  161. FDA Issues Final Rules to Help Patients Gain Access to Investigational Drugs
  162. Allergic pulmonary inflammation promotes the recruitment of circulating tumor cells t
  163. Vaccine Boosts Trastuzumab in Treatment of HER2/Neu-Positive Breast Cancer (HER2/neu
  164. Amgen's motesanib (AMG-706), VEGF inhibitor in metastatic breast cance
  165. Pitt researcher gets $2.9M for lymph node study
  166. Prolonged clinical benefit from platinum-based chemotherapy in a patient with metasta
  167. Fatal pneumonitis after treatment with docetaxel and trastuzumab.
  168. Novel anti-tubulin cytotoxic agents for breast cancer.
  169. Aldose Reductase: A Novel Therapeutic Target for Inflammatory Pathologies
  170. Einstein Researchers Identify Potential Target for Metastatic Cancer
  171. Integrin alpha2 mediates selective metastasis to the liver.
  172. Nanoparticle 'Nanobees' Deliver Bee Venom Agent to Tumors
  173. Monitoring by CTCs for metastatic bc, related to radiographic testing
  174. Stereotactic body radiation (SBRT) therapy for liver metastas
  175. Intestinal tumour chemoprevention with the antioxidant lipoic acid stimulates the gro
  176. Cancer and immunization (thread)
  177. Concurrent trastuzumab and HER2/neu-specific vaccination in patients with metastatic
  178. Underweight and Breast Cancer Recurrence and Death
  179. Editorial from the Journal of Clinical Oncology: How to treat triple postive BC
  180. Berberine-natural product against cancer and more
  181. Melatonin inhibits aromatase promoter expression
  182. Adjuvant! OnLine overestimates survival in British study
  183. Interesting Review of Tamoxifen vs. AI study results
  184. Accuracy of Conflict-of-Interest Disclosures Reported by Physicians
  185. CYP2D6 Influence on Tamoxifen Response
  186. Apomab, a fully human agonistic antibody to DR5, exhibits potent antitumor activity a
  187. Lapatinib: A competitor or companion to trastuzumab?
  188. Vitamin D good for breast cancer patients
  189. Tiny chip can measure estrogen in breast tissue
  190. Tykerb® plus Femara® Improves Quality-adjusted Survival in Women with HER2+ Metastati
  191. Targeting the Triple Threat -Triple Negative Breast Cancer
  192. Distinct inherited metastasis susceptibility exists for different bc subtypes
  193. Underuse of BC Adjuvant Treatment: Patient Knowledge, Beliefs, and Medical Mistrust
  194. Sonographic and Electrodiagnostic Evaluations in Patients With AI-Related Arthralgia
  195. Comparative Analysis of Bone Marrow Micrometastases W/SLNode Status in Early Stage BC
  196. Dasatinib (synergizes with chemo)
  197. ANG1005-Taxol derivative crosses BBB
  198. Müllerian inhibiting substance linked to increased breast cancer risk
  199. In Shift, Cancer Society Has Concerns on Screenings
  200. Lost in Transmission — FDA Drug Information That Never Reaches Clinicians
  201. Breast cancer sufferers will be denied life-extending drug (NHS: Lapatainib)
  202. MicroRNA replacement provides an effective therapy in cancer
  203. Cardiovascular Risk Greater Than Breast Cancer Recurrence Risk in Some Patients
  204. Analgesics Underused by Breast Cancer Patients
  205. Combination of bisphosphonates and antiangiogenic=more Osteteonecrosis of the jaw
  206. Comparable Results From Three Forms of Accelerated Partial-Breast Irradiation
  207. Genotyping Plus Family History May Change Breast Cancer Risk Estimates
  208. CHEK2 Mutation Increases Mortality, Breast Cancer Recurrences
  209. HER1-4 protein concentrations in normal tissue..same profile as malignant
  210. CirculatingTumor Cell and serum Her2, downloadable
  211. Noscapine: Anti-cancer couph syrup (no joke)
  212. Off-label Cancer Treatments and cocktail (website)
  213. Cancers Can Vanish Without Treatment, but How?
  214. Circadian Rhythm, eating schedule etc and treatment
  215. Update on the use of AI's in early stage BC
  216. Where to Go for Cancer Care—A Shot in the Dark
  217. Discovery of a selective Cyclin D Kinase Inhibitor that inhibts +++ bc in vitro
  218. NCCN Guidelines Discourages Prophylactic Mastectomy In Women Other Than For High Risk
  219. Gastroenterologists Explore Relationship Between Bacteria In The Gut And BC
  220. Nulliparity, Late Age at First Childbirth Linked to Aggressive Breast Cancer
  221. Cancer and Diarrhea: Rising Incidence of an Old Problem
  222. 3-bromopyruvate
  223. anti-CD25 antibody daclizumab to enhance immune responses to tumor antigen vaccinatio
  224. Gossypol: cotton derivative synergizes with chemo
  225. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB in breast cancer cel
  226. Kanzius "machine" -heated nanoparticles
  227. The HER2 and HER3 Interaction
  228. Aspirin and cancer: Patience in research
  229. Radiological staging in breast cancer: which asymptomatic patients to image and how
  230. Change in the hormone receptor status following administration of neoadjuvant chemo
  231. circulating tumor cells as a surrogate for response to treatment
  232. Tamoxifen (ER+, ER-, synergies etc)
  233. Genspera's G202: 12ADT toxin unwrapped by enzymes, "effective monotherapy"
  234. In Atypical Ductal Hyperplasia, Absence of Cytokeratin 5 Expression Is Ominous
  235. Breast cancer changes with spread
  236. T-DMI (trastuzumab plus DMI)
  237. Small, node-negative her2-positive BC much more likely than her2-negative to spread
  238. Mutational Evolution in a Lobular Breast Cancer Demonstrates Value of DNA sequencing
  239. Fluoxetine i.e. Prozac: anticancer agent
  240. Rexin-G
  241. Review: New diagnostics and biological predictors of outcomes
  242. Aspirin as anticancer agent
  243. New Method Targets Cancerous Tumors Without Harming Healthy Cells
  244. Scanning and imaging developments
  245. Sorafenib (Nexavar)
  246. Hes-6, potential oncogene in bc, is regulated by ER and promotes proliferation
  247. Repeat FISH Testing of Breast Tissue Not Cost-Effective for Her-2/neu Determination
  248. Neratinib
  249. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K
  250. Sirolimus/Rapamycin